Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shani

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
European Journal of Gynaecological Oncology|June 22, 1999
Diagnostic dilemmas and current therapy of Fallopian tube cancerH Ben-Hur, R Dgani, A Ben-Arie, et al.
Cancer Research|October 1, 1986
Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodiesE Hadas, A Fink, E Gembom, et al.
Israel Journal of Medical Sciences|August 1, 1977
Characterization of human lymphatic leukemias: T and B cell proliferationsD Zipori, A Shani, R Burstein, et al.
Cancer Letters|January 1, 1997
Subcutaneous, omentum and tumor fatty acid composition, and serum insulin status in patients with benign or cancerous ovarian or endometrial tumors. Do tumors preferentially utilize polyunsaturated fatty acids?D Yam, H Ben-Hur, R Dgani, et al.
Oncology|January 1, 1986
Diagnostic value of the computerized tube leukocyte adherence inhibition (LAI) assay for human colorectal, breast and lung cancersY Berner, A Fink, A Shani, et al.
Thrombosis Research|October 28, 2004
Libman-Sacks endocarditis associated with antiphospholipid syndrome and infectionM Blank, A Shani, I Goldberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1996
The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinomaY Kalechman, A Shani, S Dovrat, et al.
Anticancer Research|January 11, 2000
The role of blood levels of soluble 53 kDa protein and CEA in monitoring colon cancer patientsB Sandler, P Smirnoff, A Shani, et al.
Annals of Internal Medicine|May 1, 1978
Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinomaA Shani, M J O'Connell, C G Moertel, et al.
Annals of the New York Academy of Sciences|April 5, 1997
Anti-p53 autoantibodies in colon cancer patientsZ Sthoeger, E Evron, S Goland, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Gynaecological Oncology|June 22, 1999
Diagnostic dilemmas and current therapy of Fallopian tube cancerH Ben-Hur, R Dgani, A Ben-Arie, et al.
Cancer Research|October 1, 1986
Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodiesE Hadas, A Fink, E Gembom, et al.
Israel Journal of Medical Sciences|August 1, 1977
Characterization of human lymphatic leukemias: T and B cell proliferationsD Zipori, A Shani, R Burstein, et al.
Cancer Letters|January 1, 1997
Subcutaneous, omentum and tumor fatty acid composition, and serum insulin status in patients with benign or cancerous ovarian or endometrial tumors. Do tumors preferentially utilize polyunsaturated fatty acids?D Yam, H Ben-Hur, R Dgani, et al.
Oncology|January 1, 1986
Diagnostic value of the computerized tube leukocyte adherence inhibition (LAI) assay for human colorectal, breast and lung cancersY Berner, A Fink, A Shani, et al.
Thrombosis Research|October 28, 2004
Libman-Sacks endocarditis associated with antiphospholipid syndrome and infectionM Blank, A Shani, I Goldberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1996
The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinomaY Kalechman, A Shani, S Dovrat, et al.
Anticancer Research|January 11, 2000
The role of blood levels of soluble 53 kDa protein and CEA in monitoring colon cancer patientsB Sandler, P Smirnoff, A Shani, et al.
Annals of Internal Medicine|May 1, 1978
Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinomaA Shani, M J O'Connell, C G Moertel, et al.
Annals of the New York Academy of Sciences|April 5, 1997
Anti-p53 autoantibodies in colon cancer patientsZ Sthoeger, E Evron, S Goland, et al.
Pageof 10